Molecular Profiles Introduces New Nanoscale Predictive Analytical Screening Solution for APIs

24-Jan-2008

Molecular Profiles, provider of contract research services to the pharmaceutical, biopharmaceutical and biomedical sectors, announcds the latest addition to its comprehensive nanoscale analytical services offering, nanoPASS (nanoscale Predictive Analytical Screening Solution). According to the company, this new service platform is a comprehensive suite of complementary analytical techniques designed to optimise solid state selection of APIs and provide further insight into the formulation of APIs and excipients.

"The introduction of this novel service platform further demonstrates our dedication to providing a high quality and reliable extension to the R&D capabilities within pharmaceutical companies," comments Dr. Nikin Patel, CEO, Molecular Profiles. "Our team of specialised, experienced scientists will be building upon this platform to develop an extended range of service offerings intended to provide our customers with even more clarity and choice."

Other news from the department business & finance

Most read news

More news from our other portals

Under the magnifying glass: The world of microscopy